Open AccessNilotinib Approved for New Indication in Treatment of Ph-Positive CML in Chronic Phase
Publication year - 2010
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000386610.95591.fd
Subject(s) - nilotinib , medicine , imatinib , pharmacology , myeloid leukemia